On January 10, 2025, Gary Sender, a Director at iBio Inc (IBIO, Financial), purchased 9,191 shares of the company. Following this transaction, the insider now owns a total of 9,191 shares. This transaction is documented in the SEC Filing.
iBio Inc is a biotechnology company that focuses on developing plant-based biologics. The company leverages its proprietary technology to produce vaccines, therapeutics, and other biopharmaceutical products.
The insider's recent purchase is part of a broader trend within the company. Over the past year, there have been seven insider buys and zero insider sells at iBio Inc. This indicates a positive sentiment among insiders regarding the company's prospects.
On the day of the purchase, shares of iBio Inc were trading at $2.72 each, resulting in a market cap of $22.690 million for the company. This transaction reflects the insider's confidence in the company's future performance.
For more details on Gary Sender's trades, visit the insider's profile.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
